| TRESSIS CAUDAL / NARCEA I | RVI GLOBAL | 16,586943 | 28/10/2026 | 16,67% | 66,27% | **** |
| VAUGHAN NELSON U.S. SELECT EQUITY F/A (EUR) | RVI USA | 127,070000 | 29/10/2026 | 16,67% | · | ND |
| AMUNDI MSCI NORTH AMERICA ESG BROAD TRANSITION RHG DIS | RVI USA | 376,761827 | 29/10/2026 | 16,66% | 87,65% | **** |
| BELLEVUE FUNDS (LUX) - BELLEVUE AI HEALTH B CHF | RVI SALUD | 171,427022 | 29/10/2026 | 16,66% | · | ND |
| BNP PARIBAS US SMALL CAP CLASSIC EUR CAP | RVI USA SMALL/MID CAP | 639,860000 | 29/10/2026 | 16,66% | 65,43% | **** |
| FIDELITY FUNDS-GLOBAL DEFENSIVE EQUITY Y-ACC-USD | RVI GLOBAL VALOR | 26,747529 | 29/10/2026 | 16,66% | 55,60% | ** |
| ISHARES DEVELOPED WORLD SCREENED INDEX FUND (IE) INSTITUTIONAL GBP ACC | RVI GLOBAL | 23,295604 | 29/10/2026 | 16,66% | 79,98% | ***** |
| JANUS HENDERSON HF - BIOTECHNOLOGY H2 USD | RVI BIOTECNOLOGÍA | 36,109614 | 29/10/2026 | 16,66% | 113,36% | **** |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND T USD HEDGED | RVI JAPÓN VALOR | 298,209075 | 29/10/2026 | 16,66% | 90,57% | *** |
| AMUNDI FUNDS GLOBAL EQUITY CORE A USD (C) | RVI GLOBAL | 50,026954 | 29/10/2026 | 16,65% | · | ND |
